Thermo Fisher and Leading Contract Research Organizations Expand Cryo-EM Access to More Pharma and Biotech Companies August 18, 2020August 18, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmailNew program helps break down information barriers to cryo-EM adoption to speed development of more effective drugs Related News: Providing Faster Contract Analysis ServicesShimadzu…Providing Faster Contract Analysis ServicesShimadzu…Bruker Acquires Optimal Companies for Pharma PAT…Thermo Fisher Scientific & Flagship Pioneering…Thermo Fisher Scientific Awarded $192.5 Million U.S.…Thermo Fisher Scientific & Pfizer Partner to…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
